Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multikine for Perianal Warts in HIV/HPV Co-infected Patients
NCT03038828Phase 1Terminated
- Sponsor
- CEL-SCI Corporation
- Start
- Apr 2015
- Primary completion
- Jun 2018
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, open-label trial of leukocyte interleukin in perianal warts (2 cohorts), sponsored by CEL-SCI Corporation. Primary endpoint: Wart characterization change. Started Apr 2015; status: terminated.
02
Drugs
leukocyte interleukin
03
Conditions
perianal warts
Beyond the preview
Go deeper on NCT03038828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038828.